biosimilar portfolio

South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...

South Korea’s Celltrion Inc. has put its Japanese Takeda Pharmaceutical Co.'s primary care assets acquired in 2020 on sale as the biosimilar g...

South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...

South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...

FRANKFURT – Samsung Bioepis Co., a biopharmaceutical unit of South Korea’s top conglomerate Samsung, is looking to gain ground in the ra...

South Korea's biopharmaceutical company Celltrion Inc. announced on Monday that it has signed a contract with the US biotech firm Rani Therapeutics ...

MILAN – South Korea's biopharmaceutical company Celltrion Inc. is known in Europe for its biosimilar products such as autoimmune disease treat...

SK Networks Co., a South Korean trading company, is seeking to form a partnership with Silicon Valley-based venture capital firm Bow Capital to dive...

It's time again to snap up semiconductor stocks – the market darlings these days.Just like its global peers, including the New York Stock Exch...

South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...

South Korea's Samsung Bioepis has received approval in Europe to sell a biosimilar of Soliris, a drug for the treatment of adult and children patien...

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...

F&F Co., a South Korean outdoor fashion retailer, has notched a success selling US Major League Baseball (MLB) apparel in China. This comes desp...

South Korean institutional investors find secondaries and private debt attractive amid the darkening economic outlook, chief investment officers (CI...

South Korea’s LG Chem Ltd. on Tuesday revised up its 2030 sales goal for battery materials by 45% after it delivered stronger-than-expected re...

South Korea’s Celltrion Inc. is speeding up global clinical trials of its biosimilar of the multiple sclerosis (MS) treatment Ocrevus (active ...

The super-rich in South Korea are eyeing stocks for investments despite a slowdown in Asia’s fourth-largest economy this year, expecting the l...

LS Electric Co. announced on Tuesday that it has secured a contract for a £73.6 million ($93.5 million) energy storage system (ESS) project in...

South Korea's Hanwha Life Insurance said on Thursday that it has acquired a 62.6% stake in Indonesian insurer Lippo General Insurance, in collaborat...

South Korean biosimilar giant Celltrion Group aims to transform into a drug developer by generating 40% of sales from new medicines by 2030 as it is...

South Korea’s National Pension Service (NPS), one of the world’s largest pension funds, is slated to establish a committee to improve th...

In a move to expand its range of offerings, South Korean fashion company LF Corp. has introduced a new emerging brand, Patou. As the preferences of ...

South Korean fuel cell manufacturer Doosan Fuel Cell, and Kolon Global Corp., a South Korean company that specializes in the production of industria...

Celltrion Inc., South Korea’s largest biosimilar maker, said on Tuesday it has studied a possible acquisition of the biopharma solutions unit ...

South Korea's construction companies are exploring other sectors to find new growth engines amid deteriorating profitability in the housing industry...

Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...

South Korea’s biosimilar giant Celltrion Group’s founder and Honorary Chairman Seo Jung-jin is readying to return to management just two...

South Korea’s National Pension Service (NPS), with 920.4 trillion won ($694.6 billion) in assets as of November 2022, faces growing concerns o...

Japanese medical device company Olympus on Saturday said it will wholly acquire South Korea’s Taewoong Medical, a maker of gastrointestinal (G...

SM Entertainment Co., a South Korean music label widely credited as the pioneer of K-pop, has emerged as a new battlefield between HYBE Co., the age...